Bartonella henselae and B. quintana induce an unusual vascular proliferative tissue response known as bacillary angiomatosis (BA) and bacillary peliosis (BP) in some human hosts. The mechanisms of itorto/ie/fa-associated vascular proliferation remain unclear. Although host factors probably play a role, microbial coinfection has not been ruled out. Because of the vascular proliferative characteristics noted in both Kaposi's sarcoma (KS) and BA and occasional colocalization of KS and BA, the possibility was explored that KS-associated herpesvirus (KSHV) might be associated with BA lesions. Tissues with BA and positive and negative control tissues were tested for the presence of KSHV DNA by a sensitive polymerase chain reaction assay. Only 1 of 10 BA tissues, a splenic biopsy, was positive in this assay; this tissue was from a patient with concomitant KS of the skin. Thus, KSHV is probably not involved in the vascular proliferative response seen in BA-BP. Vascular proliferation is characteristic of the local tissue response to several microbial pathogens, including Bartonella bacilliformis, B. henselae, and B. quintana. When immunocompromised persons are infected with the latter two species, bacillary angiomatosis (BA) and bacillary peliosis (BP) may develop [1, 2]. In contrast, immunocompetent persons rarely develop BA-BP [3]; they more typically develop granulomatous (cat-scratch disease) and bacteremic disease (trench fever) without angioproliferation during infection with B. henselae and B. quintana, respectively [4]. At least four hypotheses explain the variable host response to B. henselae and B. quintana. First, the state of immune competence determines whether host angioproliferative factors are expressed locally; second, only certain Bartonella strains with All of the work described adhered to human experimentation guidelines of Stanford University and the University of California, San Francisco. Financial support: Donald E. and Delia B. Baxter Foundation (grant to D.A.R.); NIH (physician-scientist award AI-01360 to D.N.F.; AI-36075 and the California Universitywide AIDS Research Program to J.E.K.); Pew Scholar in the Biomedical Sciences (J.E.K.). a Present affiliations:
angiogenic potential circulate among immunocompromised persons; third, greater degrees of local Bartonella replication occur in the face of host immunosuppression, resulting in greater bacterial production of vascular proliferative factors; and fourth, BA and BP occur only in the presence of a coinfecting agent with angiogenic properties [5] .
The ability of one pathogen to modify the host response to a coinfecting organism is an increasingly common theme [6] .
Kaposi's sarcoma (KS)-associated herpesvirus (KSHV) is the putative cause of KS, a disease characterized by vascular proliferation [7] . Many of the persons at greatest risk for BA and BP are also infected with KSHV The local host cellular responses to KSHV might create a permissive or favorable environment for the formation of BA. The striking colocalization of macroscopic KS and BA cutaneous lesions in several patients (see case report below) also stimulated our interest in investigating this hypothesis. The question was whether KSHV could be detected at the molecular level in lesions that appeared to be BA without KS at the macroscopic level. Therefore, we investigated the possible coassociation of Bartonella and KSHV within the vascular proliferative lesions of BA, using assays based upon the polymerase chain reaction (PCR).
Materials and Methods
Patients and tissue specimens. We studied 10 tissue specimens with pathology typical of either BA or BP (BA1-BA10) and 3 tissue specimens with pathology typical of KS (KS1-KS3) from 13 unrelated patients, along with control samples (C1-C8), in a blinded fashion. Nine of the 10 BA-BP (herein referred to as "BA") specimens were skin lesions; all but 1 of these 9 patients were human , and tissue digestion buffer (C8). All of the tissues listed were digested using a procedure described elsewhere [1] and then sent to one of the coauthors at a different institution for further analysis.
PCR assays. A PCR assay for 16S rDNA from Bartonella species and closely related a-proteobacteria was performed with primers 12E and 24B as described elsewhere [8] . All digested tissues were tested for human 0-globin gene sequences with primers GH20 and PC04 using established conditions [8] . KSHV open-reading frame (ORF) 26 (minor capsid gene) DNA (KS330233) was detected using two primers described by Chang 2, lanes 4 and 5) and not from any digest buffer or PCR reagentonly controls ( figure 2, lanes 8-10) . By use of serial dilutions of cloned ORF 26 template DNA, the sensitivity of the KSHV PCR assay with the modified protocol was estimated to be 5 template copies (see figure 2, lanes 11-14) .
All but 1 of the 19 tissue digests yielded an amplified product of the expected size using human 0-globin gene primers on repeated testing over a 2-year period (data not shown); the exception (Cl) was positive for 0-globin DNA at the time of initial Bartonella and KSHV PCR testing; however, it was negative in the 0-globin PCR assay 2 years later, when the modified KSHV assay was performed. These results provide evidence that all of the BA and KS tissues were infected with Bartonella species or KSHV, respectively, as one would have predicted, and that the tissue digests all contained amplifiable DNA.
Assessment of KSHV infection in BA and control tissues. No evidence of KSHV DNA was found in 9 of the 10 BA specimens. From specimen BA4, a product of the expected size was detected using the modified KSHV PCR assay (figure 2,  lane 7) . BA4 was a spleen sample with typical BP histology from an HIV-seropositive patient who had biopsy-proven cutaneous KS. Four of the 6 tissue controls with normal histology were negative in this KSHV PCR assay (C1, C3, C5, C6); tissues C2 and C4 were positive despite the absence of any pathology. C2 was splenic tissue from an HIV-seropositive person with intra-abdominal lymphatic KS. This result and that from BA4 might be explained by the known ability of KSHV to disseminate within the host well beyond sites of typical KS pathology [7, 9] . The other control tissue that yielded an unexpected positive result in the KSHV assay was a liver specimen (C4) with no evidence of KS from an HIV-seropositive person with angioimmunoblastic lymphadenopathy (AILD). In one study, KSHV DNA was detected in 3 of 15 tissue specimens with this lymphoproliferative disease [10] . While our findings in this case and this study raise interesting questions about the possible role of this virus in AILD, we cannot exclude a noncausal association in a host at elevated risk for KSHV acquisition.
Discussion
KSHV has been associated with body cavity-based lymphoma, multicentric Castleman's disease, AILD, and KS. This virus encodes homologues of chemokine-like proteins vMIP-I and vMIP-II, which are angiogenic in vitro [11] . Our case and other similar cases have drawn attention over the past decade to the possibly frequent coassociation of KSHV and Bartonella species in BA lesions and a possible role for KSHV as a cofactor in the vascular proliferation of BA-BP. However, the results of our study argue against these possibilities. Our data indicate that if KSHV is found in BA lesions, it occurs infrequently or in extremely low numbers. These data suggest that KSHV is unlikely to be a cofactor in the vascular proliferation associated with BA bacilli and suggest that research efforts be focused on other possibilities. While the vascular proliferation in BA and BP may involve host induction or bacterial production of growth factors and cytokines that promote new vessel formation [12] , the exact mechanisms of this fascinating and unusual host response to infection remain to be elucidated.
